Hong-Xia YU, Yan LIU, Ming LIU, Mao-Mao ZHAO, Zeng-Hui PU

Microbiological and clinical data analysis of 32 patients with Nocardia infections in Yantai

Background/aim: Nocardia is an opportunistic pathogen that mostly affects hosts with immune deficiencies. Recently, the widespreaduse of immunosuppressive agents and antitumor drugs has led to an increasing number of Nocardia infections being reported. However,it is difficult to confirm this diagnosis owing to the slow growth of the bacterium and its complex resultant clinical manifestations,potentially delaying treatment and increasing mortality. Thus, further knowledge on the clinical characteristics of Nocardia infectionis required. Hence, this study aimed to review the demographics, comorbidities, clinical presentation, microbiology, treatment, andoutcomes of Nocardia infections in Yantai.Materials and methods: This is a retrospective study including 32 patients identified to have Nocardia infection from the YantaiYuhuangding Hospital. The relevant patient samples were collected by two researchers, while the other researchers analyzed the relevantdata.Results: The male to female ratio among the 32 patients was 3:5, and 23 patients (71.9%) were immunocompromised. Pulmonary sitesof infection were the most common (65.6% of patients). N. brasiliensis infections were present in 25.0% and N. asteroides infectionswere present in 21.9% of patients. Because of limited biotechnological resources, Nocardia spp. in 50.0% of cases were not classified. TheTMP-SMX resistance rate among isolates was 9.4%. All isolates were susceptible to amikacin, ceftriaxone, and imipenem.Conclusion: In Yantai, immunocompromised patients predominate among cases of Nocardia infection. The rate of occurrence washigher in females than in males. Because of potential TMP-SMX resistance, treatment for Nocardia infection should be based on drugsusceptibility or should include combination therapy.

PDF

___

Ribeiro MG, Salerno T, Mattos-Guaraldi AL, Camello TC, Langoni H, Siqueira AK, Paes AC, Fernandes MC, Lara GH. Nocardiosis: an overview and additional report of 28 cases in cattle and dogs. Rev Inst Med Trop Sao Paulo 2008; 50: 177- 185.
Shahapur PR, Peerapur BV, Shahapur RP, Honnutagi RM, Biradar MS. Lymphocutaneous nocardiosis caused by Nocardia otitidiscaviarum: a case report and review of literature. J Nat Sci Biol Med 2014; 5: 197-201.
Condas LA, Ribeiro MG, Gonoi T, Matsuzawa T, Yazawa K, Motta RG, Franco MM, Listoni FJ. Molecular identification and thermoresistance to boiling of Nocardia farcinica and Nocardia cyriacigeorgica from bovine bulk tank milk. Braz J Microbiol 2012; 43: 1038-1041.
Parte AC. LPSN--list of prokaryotic names with standing in nomenclature. Nucleic Acids Res 2014; 42: D613-D616.
Ishihara M, Takada D, Sugimoto K, Oguro H, Gonoi T, Akiyama Y, Yamaguchi S. Primary brain abscess caused by Nocardia otitidiscaviarum. Intern Med 2014; 53: 2007-2012.
Wang HL, Seo YH, LaSala PR, Tarrand JJ, Han XY. Nocardiosis in 132 patients with cancer: microbiological and clinical analyses. Am J Clin Pathol 2014; 142: 513-523.
Han T, Liu YM, Yang T, Dai HP, Zhang XL. A novel case of pulmonary nocardiosis with secondary hemophagocytic lymphohistiocytosis. Chin Med J (Engl) 2017; 130: 2128-2129.
Igbaseimokumo U, El Shafie S, Al Khal AL. First human infection of Nocardia Crassostreae in an immunocompetent patient. Chin Med J (Engl) 2016; 129: 114-115.
Cattaneo C, Antoniazzi F, Caira M, Castagnola C, Delia M, Tumbarello M, Rossi G, Pagano L. Nocardia spp infections among hematological patients: Results of a retrospective multicenter study. Int J Infect Dis 2013; 17: e610-e614.
Ramamoorthi K, Pruthvi BC, Rao NR, Belle J, Chawla K. Pulmonary nocardiosis due to Nocardia otitidiscaviarum in an immunocompetent host- a rare case report. Asian Pac J Trop Med 2011; 4: 414-416.
Takiguchi Y, Ishizaki S, Kobayashi T, Sato S, Hashimoto Y, Suruga Y, Akiba Y. Pulmonary nocardiosis: a clinical analysis of 30 cases. Intern Med 2017; 56: 1485-1490.
CLSI. Susceptibility Testing of Mycobacteria, Nocardiae and Other Aerobic Actinomycetes; Approved Standard-Second Edition. CLSI Document M24-A2. Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2011.
Girard V, Mailler S, Welker M, Arsac M, Cellière B, CottePattat PJ, Chatellier S, Durand G, Béni AM, Schrenzel J et al. Identification of Mycobacterium spp. and nocardia spp. from solid and liquid cultures by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Diagn Microbiol Infect Dis 2016; 86: 277-283.
Santos M, Gil-Brusola A, Morales P. Infection by Nocardia in solid organ transplantation: thirty years of experience. Transplant Proc 2011; 43: 2141-2144.
Maly K, Schirmer M. The story of CD4+CD28− T cells revisited: solved or still ongoing? J Immunol Res 2015; 2015: 348746.
Lebeaux D, Morelon E, Suarez F, Lanternier F, Scemla A, Frange P, Mainardi JL, Lecuit M, Lortholary O. Nocardiosis in transplant recipients. Eur J Clin Microbiol Infect Dis 2014; 33: 689-702.
Piau C, Kerjouan M, Le Mouel M, Patrat-Delon S, Henaux PL, Brun V, Morin MP, Gautier P, Rodriguez-Nava V, Kayal S. First case of disseminated infection with Nocardia cerradoensis in a human. J Clin Microbiol 2015; 53: 1034-1037.
Ambrosioni J, Lew D, Garbino J. Nocardiosis updated clinical review and experience at a tertiary center. Infection 2010; 38: 89-97.
Flateau C, Jurado V, Lemaître N, Loïez C, Wallet F, SaizJimenez C, Decoene C, Bergeron E, Boiron P, Faure K et al. First case of cerebral abscess due to a novel Nocardia species in an immunocompromised patient. J Clin Microbiol 2013; 51: 696-700.
Haussaire D, Fournier PE, Djiguiba K, Moal V, Legris T, Purgus R, Bismuth J, Elharrar X, Reynaud-Gaubert M, VacherCoponat H. Nocardiosis in the south of France over a 10-years period, 2004-2014. Int J Infect Dis 2017; 57: 13-20.
Eschapasse E, Hussenet C, Bergeron A, Lebeaux D. Respiratory infections caused by slow-growing bacteria: Nocardia, Actinomyces, Rhodococcus. Rev Mal Respir 2017; 34: 661-671.
Kanne JP, Yandow DR, Mohammed TL, Meyer CA. CT findings of pulmonary nocardiosis. AJR Am J Roentgenol 2011; 197: W266-W272.
Centers for Disease Control and Prevention. Nocardiosis. Atlanta, GA, USA: CDC; 2013.
Conville PS, Brown JM, Steigerwalt AG, Lee JW, Byrer DE, Anderson VL, Dorman SE, Holland SM, Cahill B, Carroll KC et al. Nocardia veterana as a pathogen in North American patients. J Clin Microbiol 2003; 41: 2560-2568.
Woo PC, Lau SK, Teng JL, Tse H, Yuen KY. Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories. Clin Microbiol Infect 2008; 14: 908-934.
Wei M, Wang P, Qu J, Li R, Liu Y, Gu L, Yang C. Identification and antimicrobial susceptibility of clinical Nocardia species in a tertiary hospital in China. J Glob Antimicrob Resist 2017; 11: 183-187.
Schlaberg R, Fisher MA, Hanson KE. Susceptibility profiles of Nocardia isolates based on current taxonomy. Antimicrob Agents Chemother 2014; 58: 795-800.
Larruskain J, Idigoras P, Marimón JM, Pérez-Trallero E. Susceptibility of 186 Nocardia sp. isolates to 20 antimicrobial agents. Antimicrob Agents Chemother 2011; 55: 2995-2998.
Lai CC, Liu WL, Ko WC, Chen YH, Tang HJ, Huang YT, Hsueh PR. Antimicrobial-resistant Nocardia isolates, Taiwan, 1998- 2009. Clin Infect Dis 2011; 52: 833-835.
Brown-Elliott BA, Biehle J, Conville PS, Cohen S, Saubolle M, Sussland D, Wengenack N, Kriel K, Bridge L, McNulty S et al. Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey. J Clin Microbiol 2012; 50: 670-672.
Uhde KB, Pathak S, McCullum I, Jannat-Khah DP, Shadomy SV, Dykewicz CA, Clark TA, Smith TL, Brown JM. Antimicrobialresistant Nocardia isolates, United States, 1995-2004. Clin Infect Dis 2010; 51: 1445-1448.